共 233 条
[1]
Baumgart DC(2012)Crohn's disease Lancet 380 1590-1605
[2]
Sandborn WJ(2010)Inflammatory bowel disease Annu Rev Immunol 28 573-621
[3]
Kaser A(2010)The natural history of adult Crohn's disease in population-based cohorts Am J Gastroenterol 105 289-297
[4]
Zeissig S(2021)Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 J Gastroenterol 56 489-526
[5]
Blumberg RS(2017)Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials Aliment Pharmacol Ther 45 1291-1302
[6]
Peyrin-Biroulet L(2004)IL-12 and IL-23: master regulators of innate and adaptive immunity Immunol Rev 202 96-105
[7]
Loftus EV(2019)IL-23 in inflammatory bowel diseases and colon cancer Cytokine Growth Factor Rev 45 1-8
[8]
Colombel JF(2010)Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab J Mol Biol 402 797-812
[9]
Sandborn WJ(2008)A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease Gastroenterology 135 1130-1141
[10]
Nakase H(2012)Ustekinumab induction and maintenance therapy in refractory Crohn's disease N Engl J Med 367 1519-1528